Parkinson's Disease Trial, By Invitation NCT06885138 Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06885138
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with idiopathic Parkinson's disease (a specific form of Parkinson's not caused by another condition) according to recognised medical guidelines.
  • People who do not have dementia, as shown by a score of 22 or more out of 30 on a standard memory and thinking test called the Montreal Cognitive Assessment.
  • People who are currently experiencing symptoms of depression.
  • People whose medication for Parkinson's movement symptoms has remained unchanged for at least 1 month.
  • People whose treatment for depression — whether medication or another type of therapy — has remained unchanged for at least 3 months.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a pacemaker, electrodes inside the skull, an implanted defibrillator, or any similar implanted device.
  • People who are currently receiving Deep Brain Stimulation treatment.
  • People who have epilepsy or have had seizures in the past.
  • People who have psychosis (a condition involving a loss of contact with reality).
  • People who have a history of a skull fracture.
  • People who are pregnant or breastfeeding.
  • People who have had thoughts of suicide or made a suicide attempt in the six months before the study begins.
  • People who have a history of dependence on or misuse of substances such as alcohol or drugs.
  • People who are currently taking certain medications that may interfere with the study treatment, including benzodiazepines, anticonvulsants, pseudoephedrine, or dextromethorphan (confirm with trial site if unsure whether a current medication is included).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Registry
ClinicalTrials.gov
Start date
23 April 2024
Est. completion
1 February 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Beck Depression Inventory-II (BDI-II); Montgomery-Åsberg Depression Rating Scale (MADRS); Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov